Detalhe da pesquisa
1.
Mapping genotypes to chromatin accessibility profiles in single cells.
Nature
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720070
2.
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Blood
; 141(17): 2047-2061, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724453
3.
Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
Acta Haematol
; 147(2): 122-132, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071966
4.
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Cancer
; 129(6): 934-945, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545710
5.
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Blood
; 137(10): 1377-1391, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871587
6.
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.
Am J Hematol
; 98(3): 502-526, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594187
7.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251406
8.
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes.
Curr Opin Hematol
; 29(2): 63-73, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34966123
9.
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept.
Curr Opin Oncol
; 33(6): 658-669, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341323
10.
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Blood
; 141(12): 1489-1493, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493344
11.
Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis.
Haematologica
; 105(1): 102-111, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004015
12.
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Transfusion
; 60(10): 2360-2369, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776542
13.
Differentiation syndrome in acute promyelocytic leukaemia.
Br J Haematol
; 187(2): 157-162, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410848
14.
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
Am J Hematol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751104
15.
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets.
Curr Oncol Rep
; 21(4): 37, 2019 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30904967
16.
Epigenetics in Cancer: A Hematological Perspective.
PLoS Genet
; 12(10): e1006193, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27723796
17.
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.
Biol Blood Marrow Transplant
; 24(8): 1754-1758, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29649620
18.
Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.
Cancer
; 123(10): 1703-1713, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192601
19.
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.
Cancer
; 123(19): 3662-3672, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759108
20.
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysis.
Haematologica
; 107(12): 2955-2960, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453519